Abstract: Method for producing a population of mammalian neurons and/or smooth muscle cells comprising contacting at least one mammalian neural stem cell with a culture medium containing one or more growth factors from the TGF-.beta. super family and detecting the differentiation of stem cell to a population of neurons or smooth muscle cells.
Abstract: Nucleic acid transporter systems for delivery of nucleic acid to a cell. The nucleic acid transporter includes a binding complex. The binding complex contains a binding molecule which non-covalently binds to the nucleic acid and covalently links to a surface ligand, nuclear ligand and/or a lysis agent. These may be linked to the binding molecule by spacers.
Type:
Grant
Filed:
June 3, 1995
Date of Patent:
November 30, 1999
Assignee:
Baylor College of Medicine
Inventors:
Savio L. C. Woo, Louis C. Smith, Richard J. Cristiano, Stephen Gottchalk, Jim Sparrow
Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
Abstract: The design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a Group I intron are described. Using this design, it is possible to construct ribozymes capable of efficiently splicing a new 3' exon sequence into any chosen target RNA sequence in a highly precise manner. A method of cell ablation is also described that provides a toxic product to a host cell in vivo in a targetted, regulated manner utilizing novel trans-splicing ribozymes of the invention. Inactive pro-ribozyme forms are also described.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
January 26, 1999
Assignees:
The General Hospital Corporation, President and Fellows of Harvard College
Inventors:
James Haseloff, Andrea Brand, Norbert Perrimon, Howard M. Goodman
Abstract: The instant invention is drawn to plasmid p1BN10 harbored in E. coli DSM 4020 and coding for a Bacillus thuringiensis endotoxin (Bt8 toxin) fused in frame to the neo gene of pBR322.
Type:
Grant
Filed:
March 4, 1987
Date of Patent:
May 14, 1996
Assignee:
Board of Trustees operating Michigan State University
Inventors:
Mark A. Vaeck, Wipa Chungjatupornchai, Lee McIntosh